Claims

Johnson & Johnson’s Talc Turmoil: Bankruptcy Court Ruling Signals Setback for Tort Claims

by

Johnson & Johnson’s legal struggles intensified as a recent bankruptcy court ruling underscored the company’s tumultuous journey regarding talc-based products. In a battle that has spanned several years, the company faced backlash over claims that its talc products contained asbestos and led to serious health issues. During a session on Wednesday, U.S. Bankruptcy Judge Michael Kaplan rejected Johnson & Johnson’s proposal to resolve thousands of lawsuits tied to its talc products through a bankruptcy filing. This decision highlighted the challenges corporations face when attempting to manage large-scale litigations in court, especially those alleging misrepresentation and … Read more

Johnson & Johnson Faces Setback in Talc Controversy as Bankruptcy Court Rejects Tort Claims

by

Johnson & Johnson faced a significant setback as a bankruptcy court ruled against its strategy to limit liabilities resulting from claims related to its talcum powder products. This ruling comes as the pharmaceutical and consumer goods giant grapples with a growing number of lawsuits alleging that its talc-based products contain cancer-causing asbestos. Recent legal maneuvers by Johnson & Johnson had aimed to manage its exposure to these lawsuits—claims that have intensified in recent years. The company had proposed a controversial plan to transfer its talc liabilities to a subsidiary that would then file for bankruptcy. … Read more

Investors Rally for Justice: Securities Class Action Filed Against Lantheus Holdings Amid Misrepresentation Claims

by

NEW YORK — A securities class action lawsuit has been launched against Lantheus Holdings, Inc., a company listed on NASDAQ under the symbol LNTH. The complaint, filed by a shareholder, seeks to represent investors who acquired Lantheus securities between February 26 and August 5, 2025. The lawsuit alleges that the defendants made false statements regarding the competitive standing of Lantheus’s key product, Pylarify, a radiopharmaceutical used in oncology. Investors who believe they have been affected by these misrepresentations are urged to consider their legal options. Shareholders who bought Lantheus securities during the specified period and … Read more

Johnson & Johnson Faces Setback as Bankruptcy Court Rejects Talc Claims

by

Johnson & Johnson’s struggles with legal battles over talc have taken a significant turn, marking a challenging period for the pharmaceutical giant. In Indianapolis, Indiana, the company faced a considerable setback related to its bankruptcy proceedings concerning claims linked to its talc-based products. Following a ruling earlier this month, a bankruptcy judge dismissed Johnson & Johnson’s attempt to create a restructured path through Chapter 11. The firm had sought to address thousands of lawsuits claiming that its talc products caused cancer. This bankruptcy maneuver was part of a broader strategy to shield itself financially from … Read more